-+ 0.00%
-+ 0.00%
-+ 0.00%

REPLIMUNE SHARES SURGE 75% AFTER CO PLANS TO RESUBMIT US APPLICATION FOR SKIN CANCER DRUG

Reuters·05/29/2026 13:41:59

Please log in to view news